Zobrazeno 1 - 10
of 168
pro vyhledávání: '"JOSE ALVIR"'
Autor:
Takao Kato, Monica Ines, Masatoshi Minamisawa, Darrin Benjumea, Denis Keohane, Jose Alvir, Ruth Kim, Yong Chen, Telma Peixoto, Matthew Kent, Jenifer Wogen, Tomonori Ishii, Aaron Crowley, Toshiya Sugino, Yasuhiro Izumiya
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 2881-2888 (2024)
Abstract Aims This study aimed to describe baseline characteristics and adherence among patients with transthyretin amyloid cardiomyopathy (ATTR‐CM) treated with tafamidis (VYNDAQEL®) in Japan using the Japanese Medical Data Vision (MDV) database.
Externí odkaz:
https://doaj.org/article/6ac02c28c3084c10b32d2e82c4af7ca5
Autor:
Haechung Chung, Cera Cantu, Cindi Pankratova, Jason Kemner, Jose Alvir, Sapna Prasad, Yong Chen
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Tafamidis is the only disease-modifying therapy approved to treat patients in the United States with transthyretin amyloid cardiomyopathy (ATTR-CM), which most commonly affects patients aged ≥ 65 years. The manufacturer operates a patient
Externí odkaz:
https://doaj.org/article/6fabde9eb056432ca8bf8cc0d6e8a045
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 2, Pp 369-378 (2024)
Abstract Introduction Tafamidis is the first drug approved by the European Commission for the treatment of wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related
Externí odkaz:
https://doaj.org/article/b41fef91209b4a70bfc1a7d61417730e
Autor:
Carmen Peral, Alfonso De Lossada Juste, Nadia Lwoff, Nataly Espinoza-Cámac, Miguel Ángel Casado, Tom Burke, Jose Alvir, Sheena Thakkar, Enrico Ferri Grazzi
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 11, Iss 1 (2024)
**Background:** Hemophilia is a congenital disorder characterized by deficiency or absence of clotting factor VIII in hemophilia A (HA) or clotting factor IX in hemophilia B (HB), resulting in frequent, repeated, and prolonged spontaneous or traumati
Externí odkaz:
https://doaj.org/article/5efc18f288da4291bf3ac5dd4d52055e
Autor:
Lisa M. Boyd, Anthony Carmine Colavecchia, Kevin A. Townsend, Laura Kmitch, Leah Broder, Rozelle R. Hegeman‐Dingle, Mohammad Ateya, Alan Lattimer, Ryan Bosch, Jose Alvir
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 8 (2023)
Background Despite guideline‐recommended use of oral anticoagulation (OAC) for stroke prevention in atrial fibrillation (AF), OAC medication adherence among patients with AF in the United States ranges from 47% to 82%. To characterize potential cau
Externí odkaz:
https://doaj.org/article/58c7ef013ec24bbeb1ed29a4d1f32cc9
Autor:
Jane Loftus, Jen Wogen, David Oliveri, Darrin Benjumea, Priti Jhingran, Yong Chen, Jose Alvir, Elena Rivero-Sanz, Jack C. Kowalik, Michael P. Wajnrajch
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundChildren with growth hormone deficiency (GHD) are treated with daily somatropin injections; however, poor treatment persistence and adherence have been recognized previously and have been shown to negatively impact growth outcomes. A recent
Externí odkaz:
https://doaj.org/article/b0c33c2a28494ac79452fab4bd05851c
Publikováno v:
Cardiology and Therapy, Vol 9, Iss 2, Pp 535-540 (2020)
Abstract Introduction In the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT; ClinicalTrials.gov number NCT01994889), tafamidis reduced the risk of all-cause mortality in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
Externí odkaz:
https://doaj.org/article/c915d0d66ca64f7eb85068516445a4e9
Publikováno v:
Perspectives in Clinical Research, Vol 4, Iss 4, Pp 221-226 (2013)
Aim: An effective clinical trial strategy to ensure patient safety as well as trial quality and efficiency involves an integrated approach, including prospective identification of risk factors, mitigation of the risks through proper study design and
Externí odkaz:
https://doaj.org/article/ba6cbde823b04a359bef4fe6683df17a
Autor:
Rahul Bhambri, A. Carmine Colavecchia, Marianna Bruno, Yong Chen, Jose Alvir, Anuja Roy, Jason Kemner, Aaron Crowley, Darrin Benjumea, Lauren Gilstrap
Publikováno v:
American Journal of Cardiovascular Drugs. 23:197-206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0aa613a48152c59ec8a7478c42d8fada
https://doi.org/10.1007/s40256-022-00563-4
https://doi.org/10.1007/s40256-022-00563-4
Autor:
Anuja, Roy, Andrew, Peterson, Nick, Marchant, Jose, Alvir, Rahul, Bhambri, Zach, Bredl, Darrin, Benjumea, Jason, Kemner, Bhash, Parasuraman
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:766-777
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ec661d0535eb1a73f8516b050ec8b1
https://doi.org/10.18553/jmcp.2022.28.7.766
https://doi.org/10.18553/jmcp.2022.28.7.766